1OBJECTIVE -To prospectively examine the effect of weight loss 1 year after laparoscopic adjustable gastric band surgery on a broad range of health outcomes in 50 diabetic subjects.RESEARCH DESIGN AND METHODS -A total of 50 (17 men, 33 women) of 51 patients with type 2 diabetes, from a total of 500 consecutive patients, were studied preoperatively and again 1 year after surgery.RESULTS -Preoperative weight and BMI (means Ϯ SD) were 137 Ϯ 30 kg and 48.2 Ϯ 8 kg/m 2 , respectively; at 1 year, weight and BMI were 110 Ϯ 24 kg and 38.7 Ϯ 6 kg/m 2 , respectively. There was significant improvement in all measures of glucose metabolism. Remission of diabetes occurred in 32 patients (64%), and major improvement of glucose control occurred in 13 patients (26%); glucose metabolism was unchanged in 5 patients (10%). HbA 1c was 7.8 Ϯ 3.2% preoperatively and 6.2 Ϯ 2.7% at 1 year (P Ͻ 0.001). Remission of diabetes was predicted by greater weight loss and a shorter history of diabetes (pseudo r 2 ϭ 0.44, P Ͻ 0.001). Improvement in diabetes was related to increased insulin sensitivity and -cell function. Weight loss was associated with significant improvements in fasting triglyceride level, HDL cholesterol level, hypertension, sleep, depression, appearance evaluation, and health-related quality of life. Early complications occurred in 6% of patients (wound infections in 4%, respiratory support in 2%), and late complications occurred in 30% of patients (gastric prolapse in 20%, band erosion in 6%, and tubing leaks in 4%). All late complications were successfully revised surgically.CONCLUSIONS -Modern laparoscopic weight-loss surgery is effective in managing the broad range of health problems experienced by severely obese individuals with type 2 diabetes. Surgery should be considered as an early intervention.
Diabetes Care 25:358 -363, 2002T here is an epidemic of obesity throughout most of the developed and much of the developing world. The prevalence of obesity (BMI Ͼ30 kg/ m 2 ) has doubled in most Western countries in the last 15-20 years. Obesity is a major independent risk factor for the development of type 2 diabetes (1) and is associated with the rapid increase in the prevalence of type 2 diabetes (2). A total of 80% of individuals with type 2 diabetes are obese (3). The risk of developing type 2 diabetes increases with the degree of obesity, duration of obesity, central weight distribution, and weight gain during adult life (4). A decrease in insulin sensitivity with increasing obesity, especially central obesity, is associated with impaired glucose tolerance, dyslipidemia, and systemic hypertension, all of which are features of the metabolic syndrome and are associated with cardiovascular risk.Early intensive treatment of type 2 diabetes and its associated vascular risk factors reduces morbidity, mortality, and poor quality of life associated with long-term macrovascular and microvascular complications (5,6). Early intensive therapy may also delay the progressive deterioration of -cell function, a characteristic of type...